Login to Your Account

Other News To Note

Tuesday, February 21, 2012

• Cancer Research UK's Cancer Research Institute in London reported that a combination of gemcitabine and drug candidate MRK003 killed cancer cells in mice with a greater effect than either drug alone. The drug is being tested in a clinical trial carried out in partnership with Cambridge University Hospitals Foundation Trust. The drug combo may have application in pancreatic cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription